全球醫藥塑膠包裝市場－按材料、產品類型、地區和競爭格局分類的產業規模、佔有率、趨勢、機會和預測（2021-2031年）

全球醫藥塑膠包裝市場預計將從 2025 年的 796.1 億美元成長到 2031 年的 1,166.2 億美元，複合年成長率為 6.57%。

此細分市場涵蓋多種聚合物容器產品，包括硬質瓶、管瓶、泡殼包裝和預填充式注射器，旨在維持藥物穩定性並確保患者安全。市場成長要素是全球慢性病發病率上升和人口老化導致對可靠給藥系統的需求不斷成長。此外，與傳統玻璃相比，塑膠固有的耐用性、輕盈性和更高的設計適應性等優勢，也持續推動其在醫藥物流領域的應用。

儘管行業發展迅速，但由於日益嚴格的環境審查和塑膠廢棄物法規結構，該行業仍面臨許多挑戰。製造商必須在滿足這些永續性要求的同時，遵守嚴格的安全標準。該行業的規模相當可觀；根據軟性包裝協會預測，到2024年，醫療和製藥應用將佔軟性包裝需求的約17%。如此龐大的市場佔有率凸顯了該行業在努力平衡醫療需求與不斷變化的環境法規時所面臨的巨大挑戰。

市場促進因素

生物製藥和注射市場的成長正在從根本上改變醫藥塑膠包裝的結構，對高性能封裝能力提出了更高的要求。複雜大分子治療藥物和GLP-1減重藥物的普及，正促使製造商加速向先進聚合物注射器和自動注射器轉型，與傳統玻璃相比，這些產品具有更優異的抗破損性和尺寸精度。這種結構性變化直接轉化為專業製造商收入的成長。例如，2024年9月，Gerresheimer公司報告稱，其塑膠器材部門在前九個月實現了9.2%的有機銷售成長，這一業績主要得益於市場對這些醫用塑膠系統的強勁需求。

同時，採用永續和環保的包裝解決方案已成為重中之重，迫使整個產業在安全性和循環經濟原則之間尋求平衡。各公司正積極採用消費後再生樹脂 (PCR) 和輕量化設計，以應對日益嚴格的環境法規和客戶的永續性目標。根據安姆科 (Amcor) 於 2024 年 10 月發布的《2024 年永續發展報告》，該公司已在全球採購超過 22.4 萬噸再生材料，以支持其向循環包裝組合的轉型。這種擴張和對永續性的關注也推動了產業的大規模整合。例如，安姆科宣布將於 2024 年以約 84 億美元的價格收購貝瑞全球公司 (Berry Worldwide Inc.)，此舉將重塑全球醫療包裝供應鏈。

市場挑戰

嚴格的塑膠廢棄物法規結構和日益嚴格的環境審查對全球醫藥塑膠包裝市場的成長構成了重大障礙。這種監管壓力迫使製造商將大量資源投入到合規性上，而非擴大產能或創新標準物流，阻礙了市場發展。企業必須應對一系列複雜的新法規，這些法規強制要求可回收性和減少廢棄物。為了滿足永續性的要求和重要的藥品安全標準，企業往往需要對包裝材料進行成本高昂的重新設計。檢驗這些環保替代方案的有效性需要耗費大量資源，造成營運瓶頸，從而有效地延長了藥品上市時間，並增加了整體生產成本。

該行業使用的材料數量龐大，凸顯了監管的緊迫性和合規的負擔。根據醫療保健塑膠回收再利用委員會預測，截至2024年，全球醫用塑膠產量預計將在2025年達到480億磅。如此龐大的數字意味著龐大的環境負擔，監管機構正努力減輕這一負擔，這也進一步收緊了醫藥包裝產業面臨的限制。

市場趨勢

在包裝上引入防偽序列化技術，以及諸如《藥品供應鏈安全法案》(DSCA) 等嚴格的追蹤要求，正在從根本上改變產業的結構。這一趨勢要求在塑膠瓶和管瓶上直接整合2D資料矩陣條碼和防篡改功能，以確保端到端供應鏈的可視性和患者安全。該行業在建立實現這種透明度所需的數位化基礎方面取得了顯著進展，超越了基本的監管合規，並邁向了​​營運最佳化。根據醫療保健分銷聯盟 (HDA) 於 2025 年 8 月發布的一項成員調查，截至 2025 年 6 月初，貿易夥伴之間在產品層面實現準確數據交換的中位數達到 98.5%，表明這些安全通訊協定已被成熟應用。

同時，智慧用藥依從性追蹤技術的整合正在將標準塑膠包裝轉變為互聯的數位資產。透過在標籤和瓶蓋中嵌入無線射頻識別 (RFID)嵌體和近距離場通訊 (NFC) 標籤，製藥公司正在醫院環境中實現自動化庫存管理和即時藥物檢驗。這種互聯性解決了庫存可見性和藥物完整性的關鍵挑戰，同時簡化了臨床工作流程。根據 Shriner MediPharm 公司 2025 年 8 月發布的新聞稿，該公司與 KitCheck 的合作已成功追蹤超過 3.25 億單位的注射用急救和麻醉劑，標誌著這些智慧包裝系統在工業規模應用方面取得了顯著進展。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球醫藥塑膠包裝市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依原料分類（聚丙烯（PP）、聚對苯二甲酸乙二醇酯（PET）、低密度聚乙烯（LDPE）、高密度聚苯乙烯（HDPE）、其他）
  • 依產品類型（固態容器、滴管瓶、鼻噴霧瓶、液體瓶、口腔清潔用品、包裝袋、管瓶和安瓿瓶、藥筒、注射器、瓶蓋和封口件、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美醫藥塑膠包裝市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國家分析
  • 美國
  • 加拿大
  • 墨西哥

7. 歐洲醫藥塑膠包裝市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國家分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

8. 亞太地區醫藥塑膠包裝市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

9. 中東和非洲醫藥塑膠包裝市場展望

• 市場規模及預測
• 市佔率及預測
• 中東和非洲：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲醫藥塑膠包裝市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國家分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進要素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 最新進展

第13章 全球醫藥塑膠包裝市場：SWOT分析

第14章 波特五力分析

• 產業競爭
• 新進入者的可能性
• 供應商電力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Gerresheimer AG
• Amcor PLC
• Berry Plastics Group Inc.
• Aptar Group Inc.
• Berk Company LLC
• Pretium Packaging LLC
• Klockner Pentaplast Group Ltd
• Comar LLC
• Gil Plastic Products Ltd
• Drug Plastics Group Inc

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Pharmaceutical Plastic Packaging Market is projected to expand from USD 79.61 Billion in 2025 to USD 116.62 Billion by 2031, registering a CAGR of 6.57%. This sector encompasses a wide variety of polymeric containment products, such as rigid bottles, vials, blister packs, and prefilled syringes, all engineered to maintain drug stability and guarantee patient safety. The market is primarily driven by the rising global incidence of chronic illnesses and an aging demographic that requires dependable medication delivery systems. Additionally, the inherent benefits of plastics, including their durability, lightweight composition, and superior design adaptability compared to conventional glass, continue to foster their adoption in pharmaceutical logistics.

Despite this growth, the industry faces a major obstacle due to mounting environmental oversight and strict regulatory frameworks regarding plastic waste. Manufacturers are compelled to manage these sustainability demands while strictly adhering to rigorous safety standards. The scale of the sector is significant; according to the Flexible Packaging Association, medical and pharmaceutical applications represented roughly 17% of flexible packaging demand in 2024. This considerable market share highlights the magnitude of the challenge as the industry attempts to balance essential healthcare requirements with evolving environmental mandates.

Market Driver

The growth of the biologics and injectable drug markets is fundamentally transforming the landscape of pharmaceutical plastic packaging, necessitating high-performance containment capabilities. As complex large-molecule therapies and GLP-1 weight-loss drugs gain popularity, manufacturers are increasingly shifting toward advanced polymer syringes and auto-injectors that offer superior break resistance and dimensional precision compared to traditional glass. This structural change is translating directly into revenue increases for specialized producers. For instance, Gerresheimer reported in September 2024 that its Plastics & Devices division achieved 9.2% organic revenue growth for the first nine months of the year, a performance largely attributed to the robust demand for these medical plastic systems.

Concurrently, the adoption of sustainable and eco-friendly packaging solutions has become a critical priority, forcing the industry to balance safety with circular economy principles. Companies are aggressively integrating post-consumer recycled (PCR) resins and lightweight designs to comply with tightening environmental regulations and client sustainability goals. According to Amcor's '2024 Sustainability Report' released in October 2024, the company procured over 224,000 metric tons of recycled material globally to support the transition toward circular packaging portfolios. This drive for scale and sustainability is also triggering major industrial consolidation, evidenced by Amcor's 2024 announcement of a definitive agreement to acquire Berry Global for approximately $8.4 billion, a move set to reshape the global healthcare packaging supply chain.

Market Challenge

Strict regulatory frameworks and intensifying environmental scrutiny regarding plastic waste represent a formidable barrier to the growth of the Global Pharmaceutical Plastic Packaging Market. This regulatory pressure hampers market progress by compelling manufacturers to allocate significant resources toward compliance efforts rather than capacity expansion or innovation in standard logistics. Companies must navigate a complex landscape of new laws demanding recyclability and waste reduction, often necessitating expensive reformulation of packaging materials to ensure they meet both sustainability mandates and critical drug safety standards. The need to validate these eco-friendly alternatives creates operational bottlenecks, effectively slowing the time-to-market for pharmaceutical products and increasing overall production costs.

The immense volume of material used in the sector amplifies the urgency of these regulations, thereby increasing the burden of compliance. According to the Healthcare Plastics Recycling Council, in 2024, global healthcare plastics production was projected to reach 48 billion pounds by 2025. This significant figure illustrates the massive environmental footprint that regulators intend to curtail, consequently tightening the constraints under which the pharmaceutical packaging industry must operate.

Market Trends

The implementation of on-pack anti-counterfeiting serialization is fundamentally reshaping the sector as manufacturers align with rigorous track-and-trace mandates like the Drug Supply Chain Security Act. This trend necessitates the integration of 2D data matrix barcodes and tamper-evident features directly onto plastic bottles and vials to ensure end-to-end supply chain visibility and patient safety. The industry has made substantial progress in establishing the digital infrastructure required for this transparency, moving beyond basic regulatory compliance to operational optimization. As noted by the Healthcare Distribution Alliance in August 2025, a member survey indicated that the median level of accurate data exchange between trading partners at the piece level had reached 98.5% as of early June, signaling a mature adoption of these security protocols.

Simultaneously, the integration of smart adherence tracking technologies is transforming standard plastic packaging into connected digital assets. By embedding Radio Frequency Identification inlays and Near Field Communication tags into labels and closures, pharmaceutical companies are enabling automated inventory management and real-time medication verification in hospital settings. This connectivity addresses critical challenges in stock visibility and drug integrity while streamlining clinical workflows. According to a press release from Schreiner MediPharm in August 2025, the company's collaboration with KitCheck has successfully captured over 325 million units of injectable emergency and anesthetic drugs to date, highlighting the substantial industrial scale of adoption for these intelligent packaging systems.

Key Market Players

• Gerresheimer AG
• Amcor PLC
• Berry Plastics Group Inc.
• Aptar Group Inc.
• Berk Company LLC
• Pretium Packaging LLC
• Klockner Pentaplast Group Ltd
• Comar LLC
• Gil Plastic Products Ltd
• Drug Plastics Group Inc

Report Scope

In this report, the Global Pharmaceutical Plastic Packaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Plastic Packaging Market, By Raw Material

• Polypropylene (PP)
• Polyethylene Terephthalate (PET)
• Low Density Polyethylene (LDPE)
• High Density Polyethylene (HDPE)
• Other

Pharmaceutical Plastic Packaging Market, By Product Type

• Solid Containers
• Dropper Bottles
• Nasal Spray Bottles
• Liquid Bottles
• Oral Care
• Pouches
• Vials and Ampoules
• Cartridges
• Syringes
• Caps and Closures
• Other

Pharmaceutical Plastic Packaging Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Plastic Packaging Market.

Available Customizations:

Global Pharmaceutical Plastic Packaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Plastic Packaging Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Raw Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Low Density Polyethylene (LDPE), High Density Polyethylene (HDPE), Other)
  • 5.2.2. By Product Type (Solid Containers, Dropper Bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials and Ampoules, Cartridges, Syringes, Caps and Closures, Other)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Pharmaceutical Plastic Packaging Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Raw Material
  • 6.2.2. By Product Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Raw Material
      • 6.3.1.2.2. By Product Type
  • 6.3.2. Canada Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Raw Material
      • 6.3.2.2.2. By Product Type
  • 6.3.3. Mexico Pharmaceutical Plastic Packaging Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Raw Material
      • 6.3.3.2.2. By Product Type

7. Europe Pharmaceutical Plastic Packaging Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Raw Material
  • 7.2.2. By Product Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Raw Material
      • 7.3.1.2.2. By Product Type
  • 7.3.2. France Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Raw Material
      • 7.3.2.2.2. By Product Type
  • 7.3.3. United Kingdom Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Raw Material
      • 7.3.3.2.2. By Product Type
  • 7.3.4. Italy Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Raw Material
      • 7.3.4.2.2. By Product Type
  • 7.3.5. Spain Pharmaceutical Plastic Packaging Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Raw Material
      • 7.3.5.2.2. By Product Type

8. Asia Pacific Pharmaceutical Plastic Packaging Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Raw Material
  • 8.2.2. By Product Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Raw Material
      • 8.3.1.2.2. By Product Type
  • 8.3.2. India Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Raw Material
      • 8.3.2.2.2. By Product Type
  • 8.3.3. Japan Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Raw Material
      • 8.3.3.2.2. By Product Type
  • 8.3.4. South Korea Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Raw Material
      • 8.3.4.2.2. By Product Type
  • 8.3.5. Australia Pharmaceutical Plastic Packaging Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Raw Material
      • 8.3.5.2.2. By Product Type

9. Middle East & Africa Pharmaceutical Plastic Packaging Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Raw Material
  • 9.2.2. By Product Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Raw Material
      • 9.3.1.2.2. By Product Type
  • 9.3.2. UAE Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Raw Material
      • 9.3.2.2.2. By Product Type
  • 9.3.3. South Africa Pharmaceutical Plastic Packaging Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Raw Material
      • 9.3.3.2.2. By Product Type

10. South America Pharmaceutical Plastic Packaging Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Raw Material
  • 10.2.2. By Product Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Raw Material
      • 10.3.1.2.2. By Product Type
  • 10.3.2. Colombia Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Raw Material
      • 10.3.2.2.2. By Product Type
  • 10.3.3. Argentina Pharmaceutical Plastic Packaging Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Raw Material
      • 10.3.3.2.2. By Product Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Pharmaceutical Plastic Packaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Gerresheimer AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Amcor PLC
• 15.3. Berry Plastics Group Inc.
• 15.4. Aptar Group Inc.
• 15.5. Berk Company LLC
• 15.6. Pretium Packaging LLC
• 15.7. Klockner Pentaplast Group Ltd
• 15.8. Comar LLC
• 15.9. Gil Plastic Products Ltd
• 15.10. Drug Plastics Group Inc

16. Strategic Recommendations

17. About Us & Disclaimer